X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-23 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $91.38 | -787 | 205,552 | 0% | -$71,915 | |||||
2024-04-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $91.38 | -531 | 117,029 | 0% | -$48,522 | ||||||
2024-04-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $91.38 | -522 | 111,677 | 0% | -$47,700 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $91.38 | -2,552 | 230,319 | -1% | -$233,200 | |||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $91.38 | -1,523 | 73,039 | -2% | -$139,171 | |||||
2024-04-19 | PNTG | Pennant Group, Inc. | Stringfield Joanne | Dir | S - Sale | $19.78 | -380 | 22,565 | -2% | -$7,516 | ||||||
2024-04-18 | SNDA | Sonida Senior Living, Inc. | Clark Reanae | See Remarks | P - Purchase | $30.11 | +3,347 | 34,431 | +11% | +$100,778 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Qureshi Danish J. | See Remarks | S - Sale | $5.93 | -12,965 | 10,801,070 | 0% | -$76,882 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $5.93 | -9,830 | 3,359,467 | 0% | -$58,292 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Pantaleoni Pablo | Chief Digital Officer | S - Sale | $5.93 | -10,116 | 1,299,927 | -1% | -$59,988 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $5.93 | -9,688 | 4,735,664 | 0% | -$57,450 | ||||||
2024-04-17 | SNDA | Sonida Senior Living, Inc. | Ribar Brandon | Pres, CEO | P - Purchase | $28.72 | +3,000 | 308,055 | +1% | +$86,160 | ||||||
2024-04-16 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.82 | -80,000 | 117,560 | -40% | -$7,265,651 | ||||||
2024-04-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.13 | -6,816 | 227,710 | -3% | -$634,797 | ||||||
| D | 2024-04-15 | ENSG | Ensign Group, Inc | Shaw Daren | Dir | S - Sale+OE | $118.96 | -4,463 | 32,250 | -12% | -$530,918 | |||||
2024-04-17 | TDOC | Teladoc Health, Inc. | Trencher Daniel | CHIEF STRATEGY OFFICER | S - Sale | $13.21 | -1,000 | 26,192 | -4% | -$13,210 | ||||||
2024-04-12 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.35 | -5,210 | 414,990 | -1% | -$106,024 | ||||||
2024-04-15 | HIMS | Hims & Hers Health, Inc. | Boughton Soleil | GC | S - Sale | $13.95 | -2,503 | 164,363 | -2% | -$34,917 | ||||||
2024-04-15 | PACS | Pacs Group, Inc. | Murray Jason Hulse | Co-Founder, CEO, COB, 10% | S - Sale | $21.00 | -1,607,142 | 62,754,551 | -2% | -$33,749,982 | ||||||
2024-04-15 | PACS | Pacs Group, Inc. | Hancock Mark | Co-Founder, Exec. Vice Chair., 10% | S - Sale | $21.00 | -1,607,142 | 62,754,551 | -2% | -$33,749,982 | ||||||
| DM | 2024-04-09 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.80 | +5 | 1,455,060 | 0% | +$64 | |||||
2024-01-03 | LFST | Lifestance Health Group, Inc. | Cipollone Paula | See Remarks | S - Sale | $7.45 | -3,369 | 290,193 | -1% | -$25,099 | ||||||
| DM | 2024-04-08 | BRTX | Biorestorative Therapies, Inc. | Silva Francisco | VP of Research, Development | P - Purchase | $1.23 | +8,308 | 167,895 | +5% | +$10,229 | |||||
2024-04-08 | SEM | Select Medical Holdings Corp | Ortenzio Robert A | Exec COB | S - Sale | $29.90 | -50,000 | 12,614,718 | 0% | -$1,495,000 | ||||||
2024-04-08 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.45 | -2,400 | 83,063 | -3% | -$49,087 | ||||||
| M | 2024-04-08 | SNDA | Sonida Senior Living, Inc. | Fryar Michael | SVP - Chief Revenue Officer | S - Sale | $28.22 | -9,194 | 87,513 | -10% | -$259,411 | |||||
| DM | 2024-04-04 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.80 | +4 | 1,455,055 | 0% | +$51 | |||||
| DM | 2024-04-04 | HIMS | Hims & Hers Health, Inc. | Baird Melissa | COO | S - Sale+OE | $14.74 | -35,253 | 538,932 | -6% | -$519,559 | |||||
| D | 2024-04-04 | HIMS | Hims & Hers Health, Inc. | Dudum Andrew | CEO | S - Sale+OE | $14.89 | -333,332 | 11,385,919 | -3% | -$4,962,693 | |||||
| M | 2024-04-04 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $21.12 | -20,923 | 85,463 | -20% | -$441,853 | |||||
2024-04-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.70 | -6,336 | 420,200 | -1% | -$137,491 | ||||||
2024-04-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $92.47 | -26,700 | 460,195 | -5% | -$2,468,822 | ||||||
2024-04-02 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $92.62 | -1,378 | 70,646 | -2% | -$127,629 | ||||||
2024-04-02 | PRVA | Privia Health Group, Inc. | Mountcastle David | EVP, CFO | S - Sale | $17.77 | -3,933 | 270,974 | -1% | -$69,889 | ||||||
| DM | 2024-04-01 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.80 | +19,240 | 1,455,051 | +1% | +$246,272 | |||||
2024-04-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 77,513 | -3% | -$140,000 | ||||||
2024-04-02 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $79.43 | -924 | 13,625 | -6% | -$73,393 | ||||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.52 | -1,000 | 83,631 | -1% | -$37,523 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale+OE | $37.60 | -6,395 | 384,553 | -2% | -$240,452 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $37.62 | -11,165 | 50,119 | -18% | -$419,979 | |||||
| M | 2024-04-01 | LIFW | Msp Recovery, Inc. | Cano Health, Inc. | 10% | S - Sale | $0.87 | -1,139,876 | 903,655 | -56% | -$996,712 | |||||
| D | 2024-04-02 | TDOC | Teladoc Health, Inc. | Nanis Nikolaos P. | CTO | S - Sale+OE | $14.31 | -461 | 70,621 | -1% | -$6,599 | |||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1,407,387 | ||||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Summy Amy B. | EVP, CMO | S - Sale | $217.29 | -3,500 | 3,975 | -47% | -$760,515 | ||||||
2024-04-01 | HIMS | Hims & Hers Health, Inc. | Boughton Soleil | GC | S - Sale | $15.65 | -2,503 | 166,866 | -1% | -$39,172 | ||||||
| D | 2024-04-01 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $21.65 | -10,000 | 33,125 | -23% | -$216,528 | |||||
2024-04-01 | ADUS | Addus Homecare Corp | Stevenson Roberton James | EVP, CHRO | S - Sale | $103.93 | -109 | 10,434 | -1% | -$11,328 | ||||||
2024-03-28 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 79,513 | -2% | -$140,000 | ||||||
| D | 2024-03-28 | CHE | Chemed Corp | Lee Spencer S | EVP | S - Sale+OE | $641.65 | -2,000 | 26,680 | -7% | -$1,283,300 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $90.16 | -1,447 | 486,895 | 0% | -$130,456 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $90.42 | -743 | 204,839 | 0% | -$67,179 | |||||
2024-03-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.42 | -707 | 197,560 | 0% | -$63,924 | ||||||
2024-03-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $90.42 | -464 | 112,199 | 0% | -$41,953 | ||||||
| DM | 2024-03-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $89.09 | -53,572 | 234,526 | -19% | -$4,772,752 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $90.42 | -914 | 72,024 | -1% | -$82,640 | |||||
| D | 2024-03-27 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.80 | -71,272 | 86,312 | -45% | -$2,694,267 | |||||
| D | 2024-03-28 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770,077 | |||||
| M | 2024-03-27 | LIFW | Msp Recovery, Inc. | Cano Health, Inc. | 10% | S - Sale | $0.69 | -50,713 | 2,043,531 | -2% | -$35,241 | |||||
| DM | 2024-03-27 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.50 | +19 | 1,435,811 | 0% | +$238 | |||||
| DM | 2024-03-27 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $9.44 | -77,136 | 139,771 | -36% | -$727,853 | |||||
| DM | 2024-03-25 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.63 | -2,902 | 86,312 | -3% | -$109,217 | |||||
| DM | 2024-03-22 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.50 | +966 | 1,435,792 | 0% | +$12,075 | |||||
| M | 2024-03-22 | LIFW | Msp Recovery, Inc. | Cano Health, Inc. | 10% | S - Sale | $0.74 | -96,102 | 2,094,244 | -4% | -$71,441 | |||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $9.37 | -38,899 | 908,104 | -4% | -$364,484 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.37 | -8,092 | 322,488 | -2% | -$75,822 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.55 | -21,438 | 143,524 | -13% | -$204,733 | ||||||
2024-03-25 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.10 | -22,163 | 164,962 | -12% | -$201,683 | ||||||
| D | 2024-03-25 | TDOC | Teladoc Health, Inc. | Geshuri Arnnon | CHIEF PEOPLE OFFICER | S - Sale+OE | $15.06 | -7,500 | 38,470 | -16% | -$112,950 | |||||
| D | 2024-03-21 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.74 | -5,826 | 86,312 | -6% | -$219,877 | |||||
2024-03-22 | SNDA | Sonida Senior Living, Inc. | Levinson Sam | 10% | P - Purchase | $9.50 | +526,316 | 2,449,593 | +27% | +$5,000,002 | ||||||
| M | 2024-03-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.28 | -6,336 | 426,536 | -1% | -$128,514 | |||||
| D | 2024-03-21 | CHE | Chemed Corp | Witzeman Michael D | VP, CFO | S - Sale+OE | $643.14 | -2,650 | 2,882 | -48% | -$1,704,321 | |||||
| D | 2024-03-20 | CHE | Chemed Corp | Judkins Brian C | VP, GC | S - Sale+OE | $645.00 | -11,158 | 1,422 | -89% | -$7,196,910 | |||||
| DM | 2024-03-19 | PTWO | Pono Capital Two, Inc. | Zuu Co. Ltd. | 10% | P - Purchase | $12.50 | +34,821 | 1,434,826 | +2% | +$435,263 | |||||
2024-03-20 | HIMS | Hims & Hers Health, Inc. | Dudum Andrew | CEO, 10% | S - Sale | $16.34 | -50,361 | 11,530,363 | 0% | -$823,055 | ||||||
2024-03-20 | HIMS | Hims & Hers Health, Inc. | Okupe Oluyemi | CFO | S - Sale | $15.82 | -9,912 | 168,627 | -6% | -$156,816 | ||||||
| M | 2024-03-19 | LIFW | Msp Recovery, Inc. | Cano Health, Inc. | 10% | S - Sale | $0.76 | -118,014 | 2,190,346 | -5% | -$89,534 | |||||
| DM | 2024-03-18 | HCA | Hca Healthcare, Inc. | Wasserman Chad J | SVP, CIO | S - Sale+OE | $327.92 | -1,220 | 1,576 | -44% | -$400,057 | |||||
| DM | 2024-03-18 | HIMS | Hims & Hers Health, Inc. | Becklund Irene | PAO | S - Sale+OE | $15.49 | -13,825 | 0 | -100% | -$214,177 | |||||
| D | 2024-03-19 | HIMS | Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Dir | S - Sale+OE | $15.52 | -10,044 | 157,874 | -6% | -$155,883 | |||||
2024-03-18 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | P - Purchase | $17.82 | +2,187 | 12,722 | +21% | +$38,963 | ||||||
2024-03-15 | LFST | Lifestance Health Group, Inc. | Burdick Kenneth A | CEO | S - Sale | $6.28 | -214,605 | 2,934,372 | -7% | -$1,347,719 | ||||||
| D | 2024-03-18 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $10.59 | -8,559 | 66,698 | -11% | -$90,661 | |||||
| D | 2024-03-18 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $10.59 | -2,008 | 29,517 | -6% | -$21,269 | |||||
| D | 2024-03-18 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $10.59 | -3,253 | 28,927 | -10% | -$34,455 | |||||
| M | 2024-03-14 | LIFW | Msp Recovery, Inc. | Cano Health, Inc. | 10% | S - Sale | $0.78 | -146,987 | 2,308,360 | -6% | -$114,462 | |||||
2024-03-14 | AGL | Agilon Health, Inc. | Kornitzer Benjamin | Chief Med., Quality Officer | P - Purchase | $0.00 | +5,434 | 62,058 | +10% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Venkatachaliah Girish | CTO | P - Purchase | $0.00 | +5,434 | 39,950 | +16% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.00 | +274,455 | 258,732 | -1746% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Desai Veeral | Chief Strategy, Dev. Officer | P - Purchase | $0.00 | +11,956 | 306,641 | +4% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Bensley Timothy | CFO | P - Purchase | $0.00 | +14,945 | 43,365 | +53% | +$0 | ||||||
| D | 2024-03-14 | ENSG | Ensign Group, Inc | Wittekind Beverly B. | VP, GC | S - Sale+OE | $121.66 | -10,000 | 37,912 | -21% | -$1,216,549 | |||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.33 | -44,540 | 4,745,352 | -1% | -$281,938 | ||||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $6.33 | -39,384 | 3,369,297 | -1% | -$249,301 | ||||||
2024-03-18 | TDOC | Teladoc Health, Inc. | Trencher Daniel | CHIEF STRATEGY OFFICER | S - Sale | $15.18 | -1,000 | 27,192 | -4% | -$15,180 | ||||||
2024-03-15 | DCGO | Docgo Inc. | Katz Steven | Dir | P - Purchase | $3.64 | +13,500 | 69,534 | +24% | +$49,140 | ||||||
2024-03-14 | DCGO | Docgo Inc. | Rosenberg Norman | CFO, Treasurer | P - Purchase | $3.61 | +10,000 | 407,419 | +3% | +$36,100 | ||||||
2024-03-15 | BTSG | Brightspring Health Services, Inc. | Yowler Jennifer | Pres, PharMerica | P - Purchase | $8.21 | +3,000 | 60,880 | +5% | +$24,630 | ||||||
2024-03-15 | BTSG | Brightspring Health Services, Inc. | Mattingly James F Jr | See Remarks | P - Purchase | $8.26 | +6,080 | 134,780 | +5% | +$50,221 | ||||||
2024-03-15 | BTSG | Brightspring Health Services, Inc. | Rousseau Jon B | See Remarks | P - Purchase | $8.09 | +36,800 | 1,395,399 | +3% | +$297,712 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |